Women's Health and Cancer Awareness

Cancer Screening and Diagnostic Innovation

Emerging work may examine multi-cancer early detection tests based on cell-free DNA, methylation patterns, and fragmentomics, together with their current limitations. Presentations will consider protein and circulating biomarkers, ovarian risk algorithms, and the role of ultrasound in triage. Researchers will discuss digital pathology, whole-slide imaging, and artificial intelligence applied to cytology and histology reporting. Rapid diagnostic centres, turnaround-time targets, and navigation support for patients with abnormal results will be explored. Attention will also be given to point-of-care tests, visual inspection methods, and specimen transport in low-resource settings. Questions of diagnostic stewardship, incidental findings, downstream overtesting, affordability, and equitable access will be raised. Quality frameworks, audit, and clear communication of uncertainty will be emphasised throughout.